Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis
Authors:
- C. CameronCCC. Cameron
- G. Le GalGGG. Le Gal
- M. A. RodgerMRM. A. Rodger
- D. CoyleDCD. Coyle
- P. S. WellsPWP. S. Wells
- T. CliffordTCT. Clifford
- E. GandaraEGE. Gandara
- G. WellsGWG. Wells
- M. CarrierMCM. Carrier
Open Access
Abstract
F1000Prime Recommended Article: Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis.Keywords
This publication has 46 references indexed in Scilit:
- Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiersBMC Medicine, 2013
- Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) TrialCirculation, 2013
- Aspirin for Preventing the Recurrence of Venous ThromboembolismNew England Journal of Medicine, 2012
- Antithrombotic Therapy for VTE DiseaseChest, 2012
- Rivaroxaban in Patients with a Recent Acute Coronary SyndromeNew England Journal of Medicine, 2012
- Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorialJournal of Clinical Epidemiology, 2011
- What to add to nothing? Use and avoidance of continuity corrections in meta‐analysis of sparse dataStatistics in Medicine, 2004
- Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort studyThe Lancet, 2003
- The Epidemiology of Venous ThromboembolismCirculation, 2003
- What's the Relative Risk?JAMA, 1998